For the Inventor, By the Inventor

Enter assignee name

Berkeley, CA, United States of America

Aduro Biotech Inc.

USPTO Granted Patents = 29

% Expired Patents = 69.0

CIPO Patents = 3

EPO Patents = 12

Trademarks = 4

Forward Citations = 407

Loading Chart...

Loading Chart...

37 inventors (with patents filed for the assignee):

Thomas W Dubensky, Jr (21 out of 53 patents)

Peter M Lauer (10 out of 10 patents)

Dirk G Brockstedt (10 out of 11 patents)

4. Meredith Lai Ling Leong (9 out of 9 patents)

5. David N Cook (8 out of 21 patents)

6. David Braun Kanne (7 out of 12 patents)

7. Keith Sadoon Bahjat (7 out of 14 patents)

8. Laura Hix Glickman (5 out of 16 patents)

9. Justin Skoble (5 out of 12 patents)

10. William G Hanson (5 out of 6 patents)

11. Edward Emile Lemmens (4 out of 4 patents)

12. William S Luckett, Jr (3 out of 3 patents)

13. John E Hearst (3 out of 22 patents)

14. George Edwin Katibah (2 out of 4 patents)

15. Leonard Sung (2 out of 8 patents)

Core Competencies:

Pyrazolopyrimidinone Compounds

Interferon Gene Signaling

Cancer Immunotherapy

Immunogenic Fusion Proteins

EGFRvIII

Cyclic Purine Dinucleotides

Listeria

Vaccine Compositions

Magnetic Nanoscale Particles

Recombinant Nucleic Acids

Attenuated Bacterial Species

29 patents: Sort by Forward Citations

1. 10738056 - Pyrazolopyrimidinone compounds and uses thereof (2020-08-11),

2. 10653774 - Compositions and methods for activating 'stimulator of interferon gene'-dependent signalling (2020-05-19),

3. 10526609 - Protein expression enhancer sequences and use thereof (2020-01-07),

4. 10449211 - Compositions and methods for activating 'stimulator of interferon gene'—dependent signalling (2019-10-22),

5. 10414789 - Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use (2019-09-17),

6. 10189873 - Compositions and methods for inhibiting 'stimulator of interferon gene'-dependent signalling (2019-01-29),

7. 10105427 - Epidermal growth factor receptor variant III-mesothelin fusions and methods of using the same (2018-10-23),

8. 9878024 - [object Object] (2018-01-30),

9. 9808516 - Immunogenic fusion proteins for the treatment of cancer (2017-11-07),

10. 9775891 - Methods and compositions for inducing an immune response to EGFRvIII (2017-10-03),

11. 9770467 - Compositions and methods for cancer immunotherapy (2017-09-26),

12. 9764013 - [object Object] (2017-09-19),

13. 9724408 - Compositions and methods for activating stimulator of interferon gene-dependent signalling (2017-08-08),

14. 9695212 - Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use (2017-07-04),

15. 9663557 - Signal peptide fusion partners facilitating listerial expression of antigenic sequences and methods of preparation and use thereof (2017-05-30),

Company Overview

Aduro Biotech Inc. is a biotechnology company based in Berkeley, California, specializing in the development of innovative immunotherapy treatments for cancer and other diseases. The company focuses on harnessing the power of the immune system to create therapies that can effectively target and eliminate cancer cells. Aduro's research encompasses various domains, including personalized medicine and novel therapeutic platforms, aiming to advance the field of oncology and improve patient outcomes through cutting-edge scientific approaches.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

29 Patents

#26 in Berkeley, CA

#2,768 in California

#11,631 in US

#22,570 in the World

Berkeley, CA, United States of America

Aduro Biotech Inc.

Forward Citations = 407

37 inventors:

Thomas W Dubensky, Jr (21 out of 53 patents)

Peter M Lauer (10 out of 10 patents)

Dirk G Brockstedt (10 out of 11 patents)

4. Meredith Lai Ling Leong (9 out of 9 patents)

5. David N Cook (8 out of 21 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aduro Biotech Inc.. Retrieved from https://idiyas.com/company/aduro-biotech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…